Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.76 |
| ▸ | RAB9A | P51151 | 8/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.71 |
| ▸ | HPGD | P15428 | 5/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.71 |
| ▸ | TP53 | P04637 | 3/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | HTT | P42858 | 3/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4929292 | 0.98 | NPC1 (0.73) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL13197417 | 0.94 | NPC1 (0.74) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL1423000 | 0.92 | NPC1 (0.67) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL38657585 | 0.92 | NPC1 (0.72) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL1422654 | 0.87 | NPC1 (0.71) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL1422765 | 0.87 | NPC1 (0.71) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL2278530 | 0.87 | NPC1 (1.00) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL1423309 | 0.87 | NPC1 (0.71) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL1422489 | 0.87 | RAB9A (0.71) | NPC1RAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL1422502 | 0.87 | NPC1 (1.00) | NPC1RAB9AALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105642355-A | Crystalline polyacid complex-based composite Fischer-Tropsch catalyst and preparation method thereof | 上海大学 | 2016-06-08 | — | — | CN | claimed |
| US-20160022658-A1 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | ABBVIE INC (US) | 2016-01-28 | — | — | US | claimed |
| EP-2974727-A1 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | Abbvie Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| CN-102503960-B | High-efficiency fluorescence crystalline material of a kind of novel triazole copper complex and preparation method thereof | FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES (CN) | 2015-11-18 | — | — | CN | claimed |
| EP-2226074-B1 | Pharmaceutical compositions and their methods of use | ABBVIE INC (US) | 2015-11-04 | — | — | EP | claimed |
| EP-2101763-B1 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | ABBOTT LAB (US) | 2012-07-18 | — | — | EP | claimed |
| EP-2226074-A2 | Pharmaceutical compositions and their methods of use | Abbott Laboratories (US) | 2010-09-08 | — | — | EP | claimed |
| US-20100029685-A1 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | NEUROSEARCH A/S (DK) | 2010-02-04 | — | — | US | claimed |
| EP-2146985-A1 | HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE | Abbott Laboratories (US) | 2010-01-27 | — | — | EP | claimed |
| EP-2101763-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | Abbott Laboratories (US) | 2009-09-23 | — | — | EP | claimed |
| EP-2079734-A1 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | NeuroSearch A/S (DK) | 2009-07-22 | — | — | EP | claimed |
| WO-2008127464-A1 | HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE | ABBOTT LABORATORIES (US) | 2008-10-23 | — | — | WO | claimed |
| US-20080255203-A1 | HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE | ABBOTT LABORATORIES (US) | 2008-10-16 | — | — | US | claimed |
| US-20080167286-A1 | Pharmaceutical compositions and their methods of use | ABBOTT LABORATORIES (US) | 2008-07-10 | — | — | US | claimed |
| WO-2008073942-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | ABBOTT LABORATORIES (US) | 2008-06-19 | — | — | WO | claimed |
| WO-2008049864-A1 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | NEUROSEARCH A/S (DK) | 2008-05-02 | — | — | WO | claimed |
| EP-2630675-B1 | ORGANIC LIGHT-EMITTING DEVICE AND METHOD | CAMBRIDGE DISPLAY TECH LTD (GB) | 2019-09-11 | — | — | EP | disclosed |
| CN-105642355-A | Crystalline polyacid complex-based composite Fischer-Tropsch catalyst and preparation method thereof | 上海大学 | 2016-06-08 | — | — | CN | disclosed |
| WO-2008073942-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | ABBOTT LABORATORIES (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008049864-A1 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | NEUROSEARCH A/S (DK) | 2008-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255203-A1 | HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE | CYP11B2, AADAC, CYP11B1 | NPC1 473/4885RAB9A 3859/4885ALDH1A1 292/4885 |
| US-20080167286-A1 | Pharmaceutical compositions and their methods of use | CHRNA4, CHRNB4, CHRNA5 | NPC1 1677/4885RAB9A 1978/4885ALDH1A1 2267/4885 |
| US-20160022658-A1 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | CHRNA4, CHRNB4, CHRNA5 | NPC1 1677/4885RAB9A 1978/4885ALDH1A1 2267/4885 |
| US-20100029685-A1 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | CHRNA3, CHRNA5, CHRNB3 | NPC1 4031/4885RAB9A 3855/4885ALDH1A1 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.